FF

FutureFuel Corp. 10-K Summary (Fiscal Year Ended Dec 31, 2008)

Business Context and Reporting Period

FutureFuel Corp. is a Delaware corporation formed as a special purpose acquisition company that acquired FutureFuel Chemical Company (formerly Eastman SE, Inc.) in October 2006. The company operates a manufacturing facility in Batesville, Arkansas, producing specialty chemicals and biofuels (primarily biodiesel). The reporting period covers the fiscal year ended December 31, 2008. The company's common stock is quoted on the OTCBB under the symbol "FTFL."

Key Financial Metrics

Segment Performance (2008): Chemicals segment revenue was $155.6 million (79% of total); Biofuels segment revenue was $42.8 million (21% of total). The Biofuels segment achieved a gross margin of $7.7 million in 2008, compared to a gross loss of $9.9 million in 2007.

Material Changes vs. Prior Period

• Revenue Growth: Total revenue increased 17% year-over-year, driven by a 69% increase in biofuels revenue and an 8% increase in chemicals revenue.
• Profitability Surge: Net income increased 169% to $22.7 million. This was significantly aided by $9.5 million in hedging gains in the biofuels segment due to declining energy prices in late 2008, offsetting a $4.0 million inventory write-down.
• Dividend Payment: The company declared and paid a special cash dividend of $0.70 per share in 2008, totaling $19.7 million.
• Customer Concentration: Two customers (Procter & Gamble and Arysta LifeScience) accounted for approximately 60% of total revenues in 2008.

Guidance, Outlook, and Risks

Outlook and Strategy: Management intends to expand biodiesel capacity to 59 million gallons per year by April 2009. The company plans to fund capital expenditures through operating cash flow, existing cash, and a $50 million credit facility (currently unutilized). Future growth relies on expanding the biofuels platform and leveraging co-products like glycerin.

Key Risks and Contingencies:

• Tax Credit Expiration: The federal biodiesel tax credit ($1.00/gallon) is set to expire on December 31, 2009. Management warns that without extension, production margins could turn negative, potentially forcing a cessation of biodiesel production.
• Customer Concentration: Loss of the two primary customers (representing 60% of revenue) would have a material adverse effect.
• Market Volatility: Biodiesel profitability is highly sensitive to the spread between crude oil prices and feedstock costs. Excess industry capacity poses a risk to pricing power.
• Legal Proceedings: The company is involved in disputes regarding a defaulted construction contract and a biodiesel sales contract default, though management does not expect these to have a material impact on financial condition.

Investor Verification Checklist

• Tax Credit Status: Verify the legislative status of the federal biodiesel tax credit extension beyond December 31, 2009, as this is critical to future margins.
• Customer Contracts: Review the terms and expiration dates of contracts with Procter & Gamble and Arysta LifeScience to assess revenue stability.
• Inventory Valuation: Confirm the adequacy of inventory reserves given the volatility in commodity prices and the $4.0 million write-down recorded in 2008.
• Capital Expenditure Progress: Monitor the completion timeline and cost of the biodiesel capacity expansion project scheduled for April 2009.
• Liquidity Position: Assess the company's ability to service debt and fund operations if the credit facility is needed, given the reduction in cash balances from the special dividend.